Plerixafor

NDC 68083-155 · Gland Pharma Limited

Generic namePlerixafor

Dosage formINJECTION, SOLUTION

RouteSUBCUTANEOUS

Active ingredient(s)PLERIXAFOR

Strength24 mg/1.2mL

Pharmacologic classHematopoietic Stem Cell Mobilizer [EPC], Increased Hematopoietic Stem Cell Mobilization [PE]

Marketing categoryANDA

Packages

68083-155-01 — 1 VIAL in 1 CARTON (68083-155-01) / 1.2 mL in 1 VIAL

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0024-5862 — PLERIXAFOR, 25021-416 — Plerixafor, 31722-373 — Plerixafor, 43598-308 — Plerixafor, 55150-356 — Plerixafor, 65219-284 — PLERIXAFOR, 70121-1694 — plerixafor, 70710-1208 — plerixafor, 70771-1776 — plerixafor, 71288-155 — Plerixafor, 72162-2642 — Plerixafor, 72205-249 — Plerixafor

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q4 (October 2026 release). All data sources · How to read the labels

Current data releases:ICD-10-CM FY2027 · ICD-10-PCS FY2027 · HCPCS October 2026 · MS-DRG v44 · Medicare Code Editor v44.0 · NCCI PTP Q4 2026 · MUE Q4 2026 · NCD code lists 2026-01 · LCD export September 28, 2026 · All releases and sources